Posts Tagged

Fraud

A large-scale intervention in the individual health market The US Centers for Medicare & Medicaid Services in September 2026 said it had cancelled about 315,000 Affordable Care Act policies covering roughly 760,000 people in August 2026. The agency cited unverified citizenship or immigration documentation and suspected improper enrolments. It also moved to exclude 569 brokers whose 2026 applications allegedly showed statistically implausible patterns or lacked essential applicant information. The

A group including NatWest, Bank of America, ING, Capital One, Commonwealth Bank of Australia and ASB has warned that AI shopping agents can create fraud, privacy and recourse risks. The banks’ proposed principles include disclosing when an agent is acting, explaining material decisions, protecting data and preserving consumer choice and interoperability. These are industry proposals, not a binding global standard. From search assistance to delegated action The issue is

The May 2026 NBER Digest discusses Competition and Fraud in Health Care, Working Paper 34802, issued in February. The study examines Medicare procurement of durable medical equipment after a move from administered prices to competitive bidding. The authors find that fraudulent firms gained market share as legitimate providers exited, reflecting a cost advantage for fraudulent operators. The findings concern a specific setting. They do not establish the same outcome

Anbang Insurance’s founder and former chairman Wu Xiaohui in May 2018 was sentenced to 18 years in prison after being convicted of fraud in fundraising and of embezzlement by the Shanghai No. 1 Intermediate People’s Court. Anbang’s fast growth was driven by high-yield, investment-type insurance products with redemption options. Its asset management practices may have resulted in a duration mismatch between assets and liabilities. Wu in June 2017 was